Meklēt izmeklēšanas

The case concerned how the European Commission handled a complaint alleging that Italy has failed to fully transpose Directive 82/76/CCE on the mutual recognition of diplomas in medicine into national law. The complainant contended that the Italian legislation transposing the Directive, as well as related case law, does not guarantee appropriate remuneration for all doctors who attended training for medical specialists from 1982 to 1991.

The Ombudsman opened an inquiry asking the Commission to address in more detail the complainant’s arguments. In the course of the inquiry, the Commission set out its position that there was no breach of EU law in a clear and reasonable manner. The Ombudsman finds no manifest error by the Commission and thus closes the case with a finding of no maladministration.

The case concerned how the European Labour Authority’s (ELA) assessed the complainant’s professional experience in a selection procedure for recruiting programming and reporting officers.

The Ombudsman found nothing to suggest a manifest error in the selection committee’s assessment of the complainant’s qualifications. The Ombudsman therefore closed the inquiry with a finding of no maladministration.

The complaints concerned the European Commission’s decision not to extend funding for those carrying out research under the EU-funded Marie Skłodowska-Curie Action Programme (MSCA) following the impact of the COVID-19 crisis on the work of researchers. The complainants considered that the measures the Commission put in place to support MSCA researchers during the COVID-19 crisis were insufficient, as they would not enable them to continue their work.

The Ombudsman opened an inquiry into how the Commission communicated with project partners that received grants under the MSCA, and the researchers carrying out the work for those project partners, about the measures they could take to address the impact of the COVID-19 crisis on their projects.

During the inquiry, the Ombudsman shared her preliminary findings with the Commission. In particular, the inquiry showed that, overall, the Commission had taken appropriate action to communicate the measures that could be taken to support researchers according to the applicable rules. However, as no solution had been found for the complainants, she urged the Commission to explore whether additional funding could exceptionally be awarded to the complainants and researchers in similarly difficult situations.

The Commission broadly accepted the Ombudsman’s preliminary findings but reiterated that, due to legal and financial constraints, it cannot provide any exceptional funding.

The Ombudsman appreciates the difficult situation faced by many MSCA researchers due to the COVID-19 crisis. At the same time, she acknowledges the Commission’s commitment to find solutions within the applicable rules for those researchers impacted. While it is regrettable that a solution could not be found for the complainants and researchers in similar situations, the Ombudsman closed the case as further inquiries would not result in a more satisfactory outcome for the complainants. However, she made two suggestions for improvement.